Too Much or Too Little Milk? Your Hormones Are Trying to Tell You Something
You've tried the lactation cookies. You've chugged the fenugreek tea. You've power-pumped until your flanges feel like a permanent extension of your body, and your supply still isn't where you need it to be.
Maybe the opposite is your reality: you're drowning in milk, soaking through breast pads by the hour, battling engorgement and recurring plugged ducts while your baby chokes and sputters at every feed.
Here's what most generic breastfeeding advice isn't telling you: whether your supply is too low or wildly too high, your body may be sending you an important signal about your endocrine system, because the hormonal command center governs far more than just your milk production. The emerging research on lactation physiology is clarifying something many experienced IBCLCs (International Board Certified Lactation Consultants) have observed for years: both low milk supply and hyperlactation can be rooted in endocrine dysfunction, and that dysfunction has implications for your long-term health, not just your breastfeeding journey.
The Hormonal Architecture of Milk Production
Before we talk about what goes wrong, it helps to understand what's supposed to go right. Lactation is not a simple on/off switch, it's a sophisticated, hormone-orchestrated cascade that involves your brain, your endocrine glands, and even your metabolic health. These hormones do not operate in isolation. They perform, as one expert aptly described, a synchronized dance and when one steps out of rhythm, the entire choreography suffers. The key hormonal players are:
Prolactin: Secreted by the anterior pituitary gland in response to nipple stimulation, prolactin is the primary driver of milk synthesis. It operates on a supply-demand feedback loop: more stimulation means more prolactin, which means more milk. Prolactin also runs on a positive feedback loop, meaning the more your body releases, the more your pituitary is stimulated to keep releasing it. This is why early and frequent stimulation in those first hours and days matters so much.
Oxytocin: Released from the posterior pituitary in response to sensory cues (seeing, hearing, smelling, or touching your baby) and the physical pull of the nipple during nursing. Oxytocin triggers the milk ejection reflex, your let-down. Stress and pain actively suppress oxytocin release, which is why pumping in a high-stress environment can feel fruitless even when supply is technically adequate. Because most available milk requires active oxytocin-triggered ejection to be released, suction alone only accesses a fraction of what's actually there. That's why achieving multiple let-downs per session matters far more than most people realize. (For the full breakdown of letdown physiology and how to work with your nervous system, read the Milk Letdown Signs & Techniques guide.)
Estrogen & Progesterone: During pregnancy, these hormones are elevated specifically to suppress prolactin because your body is smart enough to know it's not time yet. The precipitous drop in estrogen and progesterone after delivery (triggered by the complete delivery of the placenta) is the biological green light for full milk production. This transition is called Lactogenesis II. Any disruption to this hormonal drop, whether from retained placental fragments, hormonal dysregulation, or other endocrine interference can delay or impair that launch.
Insulin: Often the underappreciated player in lactation physiology, insulin plays a critical role in the breast's sensitivity to prolactin. It facilitates the uptake of glucose into the mammary gland — a non-negotiable fuel source for milk synthesis — and ensures the cellular machinery is responsive to the signals telling it to make milk. Over the last several years, research has established that insulin-sensitive gene expression is dramatically upregulated specifically during the lactation cycle, confirming that insulin plays a direct role in secretory differentiation, secretory activation, and ongoing milk production.
Thyroid Hormones (T3, T4, TSH): Thyroid hormones modulate your metabolic rate, prolactin regulation, and the overall efficiency of every endocrine process in your body. Their role in lactation is well-documented enough that clinical guidelines recommend thyroid assessment as part of any comprehensive lactation workup. The thyroid essentially sets the metabolic tempo that every other hormone in this system relies on.
Low Milk Supply: When the Endocrine System Underperforms
Approximately 10–15% of mothers experience clinically significant low milk supply (LMS), but that percentage doesn't fully capture those who experience a suboptimal supply that never quite reaches the threshold of clinical concern. These are the mothers who are told "everything looks fine" while they know something isn't right. A landmark 2024 review published in Advances in Nutrition identified estrogen and progesterone dysregulation as central mechanisms underlying LMS, alongside a complex interaction with external hormonal exposures (Jin et al., 2024). The conversation doesn't stop there.
PCOS and Insulin Resistance: The Missing Link
Polycystic Ovary Syndrome (PCOS) is a hormonal condition affecting an estimated 5–13% of women and is characterized by elevated androgens, irregular cycles, and, critically, insulin resistance. The same hormonal disruptions that complicate conception in PCOS can complicate lactation. Recent clinical evidence has identified insulin resistance as a likely disruptor of milk production at the cellular level. Insulin sensitivity is required for the mammary gland's uptake of glucose as the primary fuel for milk synthesis. When cells resist insulin, the energy supply to the lactocytes (milk-producing cells) can be impaired, even when prolactin levels are completely normal. This is a crucial nuance: you can have adequate prolactin and still have compromised milk production if insulin resistance is interfering with the downstream cellular response.
The research on PCOS and breastfeeding outcomes is still evolving and contains some important nuance worth understanding. A case-control study by Vanky et al. found that mothers with PCOS had lower exclusive breastfeeding rates at one month postpartum (75% vs. 89% in controls) and higher rates of not breastfeeding at all (14% vs. 2%). However, by three to six months postpartum, breastfeeding rates between PCOS and non-PCOS mothers equalized, suggesting that the most significant impact may occur in the early postpartum window, potentially through delayed Lactogenesis II or initial low supply (Vanky et al., 2008; Joham et al., 2016). Additionally, more recent data (Bui et al., 2025) found that obesity, which affects up to 85% of the PCOS population, was actually a stronger independent predictor of decreased breastfeeding initiation than PCOS status alone. This doesn't mean PCOS doesn't matter. It means that the metabolic components of PCOS, particularly insulin resistance, may be the mechanistic drivers rather than the diagnosis itself. That's an important distinction, because insulin resistance doesn't require a PCOS diagnosis to be present, and it doesn't require obesity or a high BMI to be clinically significant. Lean women with PCOS and women without PCOS entirely can experience insulin resistance that silently undermines their milk supply.
Thyroid Dysfunction and Lactation
Thyroid imbalances: hypothyroidism, hyperthyroidism, Hashimoto's thyroiditis all have documented connections with impaired lactation. Prolactin is regulated in part through pathways involving the thyroid, and disruptions in thyroid hormone production can interfere with prolactin's synthesis and release. The thyroid gland also regulates the metabolic rate your mammary gland depends on to do its job.
Postpartum thyroiditis deserves particular attention here. This autoimmune condition, in which the immune system attacks the thyroid gland in the months after delivery, affects approximately 5–10% of postpartum women and the incidence is even higher in those with pre-existing autoimmune disorders like type 1 diabetes or a family history of thyroid disease. Postpartum thyroiditis typically follows a two phase course: an initial hyperthyroid (overactive) phase, followed by a hypothyroid (underactive) phase that usually hits between four and eight months postpartum. That timing is precisely the window when many mothers find their supply suddenly and inexplicably declining. The hypothyroid phase can present as fatigue, brain fog, depression, cold sensitivity, and critically a dropping milk supply. Because these symptoms overlap heavily with normal postpartum exhaustion, thyroid dysfunction is frequently overlooked, making full thyroid lab panels critical clinical tools for assessments.
The American Thyroid Association recommends treating subclinical and overt hypothyroidism in lactating women who wish to breastfeed. Some mothers find that even a TSH within the "normal" laboratory range isn't sufficient for their body to maintain a full supply as their personal set point may require optimization within the upper portion of the reference range (Australian Breastfeeding Association; LactMed, 2025). Research also suggests that as many as 25% of women with PCOS may have a coinciding thyroid disorder, meaning these conditions are not always separate conversations but deeply intertwined.
Delayed Lactogenesis II: When the Launch Stalls
Lactogenesis II is the transition from colostrum to transitional (and then mature) milk and typically occurs 48–72 hours postpartum and is directly hormone-dependent. Any condition that hinders the postpartum drop in progesterone (such as retained placental fragments) or impairs insulin sensitivity (like gestational diabetes, preexisting diabetes, or PCOS) can delay this transition. Delayed Lactogenesis II is one of the most well-documented risk factors for early breastfeeding cessation, and it is often miscategorized as simply "not making enough milk" without identifying the underlying endocrine cause. Delayed secretory activation has been observed more frequently in women with metabolic disorders, including those with insulin resistance (Nommsen-Rivers et al., 2010; Vanky et al., 2008).
Note: These are not the only reasons for a delay in Lactogenesis II, but they are the primary endocrine-related ones relevant to this discussion.
Hyperlactation (Oversupply): When the System Overshoots
When low supply is a frustrating emotional puzzle, oversupply is often the breastfeeding problem nobody warns you about. Hyperlactation is producing significantly more milk than your baby requires and is frequently dismissed as a "good problem to have," yet the lived experience of persistent engorgement, recurrent mastitis, forceful let-down, inability to find comfort, and a baby who struggles to feed tells a very different story. Here's what the literature makes increasingly clear: hyperlactation is not always just a management issue (i.e. too much pumping). For a group of mothers, it has genuine endocrine roots, which comes with serious health risks.
Hyperprolactinemia: The Prolactin Overload
Excessively elevated prolactin levels (hyperprolactinemia) is a documented cause of excessive milk production. This can arise from prolactinomas, benign pituitary tumors, that are the most common type of hormone-secreting pituitary adenoma, accounting for approximately 50% of all pituitary adenomas. Other types of pituitary tumors can also drive oversupply by compressing the pituitary stalk and disrupting dopamine-mediated prolactin inhibition, and certain medications (including some antipsychotics, anti-nausea drugs, and antidepressants) can elevate prolactin as a side effect. When hyperprolactinemia drives oversupply, it is a medical condition warranting evaluation and treatment, not just block feeding.
An important nuance: prolactinoma outcomes in breastfeeding are highly variable. Some mothers with prolactinomas experience significant oversupply, while others paradoxically struggle with low supply, particularly if they were on dopamine agonist therapy (cabergoline or bromocriptine) prior to or during pregnancy. The relationship between prolactinoma, treatment history, and lactation outcome is more complex than a simple "more prolactin equals more milk" equation, and it underscores the importance of individualized monitoring.
Estrogen and Progesterone: The Postpartum Imbalance
The postpartum estrogen-progesterone drop is supposed to be a clean, swift handoff to prolactin. In some women, hormonal imbalances including unusually rapid or exaggerated drops can cause prolactin to surge beyond what the baby's demand warrants. Women who have estrogen-progesterone dysregulation in other areas of their reproductive health (irregular cycles, endometriosis, PCOS) may be more susceptible to this postpartum hormonal overshoot. The oversupply in these cases can also be volatile meaning you shouldn't bank on it always being there, and the trajectory may shift as hormones continue to recalibrate.
Thyroid and Oversupply: An Underscreened Connection
Clinical guidelines for the management of breast milk oversupply explicitly recommend thyroid function assessment in mothers presenting with hyperlactation (Trimeloni & Spencer, 2016). The mechanism is not entirely clear, but the clinical observation is consistent: thyroid dysfunction can drive abnormal milk production patterns in both directions. Some mothers with hyperthyroidism report large milk supplies, while others struggle with letdown. This means you could theoretically swing from oversupply to low supply, or experience confusing fluctuations if thyroid dysfunction is left untreated or only partially managed.
Why Your Milk Supply Problem Is Also a Maternal Health Problem
This is the part of the conversation that rarely happens in a standard postpartum appointment. And it matters enormously. When your milk supply problems are rooted in endocrine dysfunction, that dysfunction does not begin and end with breastfeeding. Conditions like PCOS, insulin resistance, and thyroid disorders have long-term implications for metabolic health, cardiovascular risk, and reproductive wellness, implications that extend decades beyond the postpartum period.
PCOS and insulin resistance, left unmanaged, significantly elevate the lifetime risk of type 2 diabetes, metabolic syndrome, and cardiovascular disease. Thyroid disorders, left unmanaged, affect cognitive function, mood, weight regulation, and fertility. Persistent hyperprolactinemia beyond the breastfeeding relationship can cause bone density loss, irregular cycles, and infertility. Your health matters. Pregnancy and lactation are sometimes the first recognized signals of a broader health picture that deserves comprehensive attention. The lactation journey is not just about feeding your baby, it can be a window into your own endocrine health. Your care providers should be collaborating with you to ensure that window doesn't get ignored.
The Bottom Line
Now that you understand the why, what do you actually do about it? Part 2 of this series: When Your Hormones Are the Problem, breaks down the evidence-based action plan. Which labs to ask for, how to support your blood sugar, which supplements have real science behind them, and how to approach thyroid treatment and the mechanics of milk removal together. If you're navigating supply challenges in either direction and the standard advice isn't landing, book a consultation. We'll look at the full picture together: your history, your symptoms, your goals, and what your body may be telling you beneath the surface. If you can’t get in with me, snag a session with Jessica of Genuine Lactation!
-
Yes. Endocrine conditions like insulin resistance, thyroid dysfunction, and PCOS can impair milk production at the cellular level. Meaning it can be independent of how well your latch looks or how frequently you're removing milk. Adequate prolactin alone isn't enough if the downstream hormonal machinery isn't functioning properly. This is exactly why a comprehensive evaluation matters when supply doesn't respond to standard interventions.
-
Absolutely. This could be from a normal hormonal shift (baby eating solids more) or from postpartum thyroiditis that follows a biphasic pattern, and the hypothyroid phase typically hits between four and eight months postpartum, exactly the timeline you're describing. This condition affects roughly 5–10% of postpartum women and is frequently misattributed to normal supply regulation or attributed to "just how breastfeeding goes." If your supply dropped suddenly without a clear change in your routine, a thyroid panel is worth requesting.
-
Yes. Insulin resistance does not require obesity or a high BMI to be clinically significant. Lean women with PCOS can absolutely experience insulin resistance that affects the mammary gland's ability to take up glucose for milk synthesis. This is one of the most frequently missed connections in lactation care.
-
Not necessarily. Persistent hyperlactation causes real physical suffering, engorgement, recurrent mastitis, forceful let-down that makes feeding difficult for your baby, and chronic discomfort. More importantly, when oversupply is driven by an underlying condition like hyperprolactinemia or thyroid dysfunction, it signals that something in your endocrine system warrants medical evaluation beyond standard breastfeeding management.
-
If you have unexplained or persistent supply issues in either direction, and especially if you have a history of PCOS, thyroid problems, gestational diabetes, irregular cycles, or difficulty conceiving, a comprehensive hormonal and metabolic workup is a reasonable starting point. Part 2 of this series details exactly which basic labs to request. If your provider isn't receptive, book a consult and we'll help you build your case and your care team.
Scientific References
Jin X, et al. Causes of Low Milk Supply: The Roles of Estrogens, Progesterone, and Related External Factors. Advances in Nutrition. 2024;15(1):100129.
Trimeloni L, Spencer J. Diagnosis and Management of Breast Milk Oversupply. Journal of the American Board of Family Medicine. 2016;29(1):139–142.
van Veldhuizen-Staas CGA. Overabundant Milk Supply: An Alternative Way to Intervene by Full Drainage and Block Feeding. International Breastfeeding Journal. 2007;2:11.
Hannan FM, et al. Hormonal Regulation of Mammary Gland Development and Lactation. Nature Reviews Endocrinology. 2023;19:46–61.
Bilos LSK. Polycystic Ovarian Syndrome and Low Milk Supply: Is Insulin Resistance the Missing Link? Endocrine Oncology and Metabolism. 2017;3(2):49–55.
Nommsen-Rivers LA, et al. Delayed Onset of Lactogenesis Among First-Time Mothers Is Related to Maternal Obesity and Factors Associated With Ineffective Breastfeeding. American Journal of Clinical Nutrition. 2010;92(3):574–584.
Nommsen-Rivers LA. Does Insulin Explain the Relation Between Maternal Obesity and Poor Lactation Outcomes? An Overview of the Literature. Advances in Nutrition. 2016;7(2):407–414.
Vanky E, et al. Breastfeeding in Polycystic Ovary Syndrome. Acta Obstetricia et Gynecologica Scandinavica. 2008;87(5):531–535.
Joham AE, et al. Polycystic Ovary Syndrome, Obesity, and Pregnancy. Seminars in Reproductive Medicine. 2016.
Bui LM, et al. Obesity but Not Polycystic Ovary Syndrome Associated With Decreased Breastfeeding Initiation Rates. Breastfeeding Medicine. 2025;20(5):327–337.
American Thyroid Association / LactMed. Thyroid Hormones and Breastfeeding — NCBI Bookshelf. Updated 2025.
Marasco L, et al. Hormonal Imbalances & Insufficient Milk — Categorical Bibliography. University of Montana Breastfeeding Learning Collaborative. 2024.
Melmed S, et al. Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism. 2011.
